P., et al
The Endocrinology of Taste Recptors
Phenomixs CEO Mark Bagnall spoke with Pharmaceutical Executive about this data and what the impact is on GLP-1 users
Despite this, Novo Nordisk remains committed to CagriSema as the potential first approved GLP-1 and amylin combination product
10.1007/s00198-018-4649-8 Summary Keywords glucagon-like peptide-1, diabetes mellitus, glucagon-like peptide 1 receptor agonists, osteoporosis, bone resorption Citation Xie B, Chen S, Xu Y, Han W, Hu R, Chen M, Zhang Y and Ding S (2021) The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment
The glucagon-like peptide-1 receptor (GLP1R) is a G protein-coupled receptor (GPCR) found on beta cells of the pancreas and on neurons of the brain